Table 1 Demographics and clinical characteristics between the CAP and control groups
Variable | CAP (n = 103) | Control(n = 52) | P-values |
|---|---|---|---|
Gender, n (%) male | 60(58.3) | 23(44.2) | 0.125 |
Age(years) | 73.0(64.0,83.5) | 68.0(59.0,77.5) | 0.096 |
Systolic pressure(mmHg) | 131.4 ± 20.28 | 132.9 ± 18.97 | 0.658 |
Diastolic pressure(mmHg) | 76.0(67.5,86.0) | 78.0(71.5,87.5) | 0.266 |
Comorbidities, n (%) | |||
Hypertension | 56(54.4) | 34(65.4) | 0.229 |
Diabetes mellitus | 29(28.2) | 18(34.6) | 0.461 |
Malignancy | 7(6.8) | 2(3.8) | 0.719 |
Kidney disease | 11(10.7) | 4(7.7) | 0.775 |
ALT(IU/L) | 15.0(9.0,23.0) | 19.5(11.5,27.0) | 0.125 |
AST(IU/L) | 20.0(15.0,27.0) | 18.0(15.0,26.0) | 0.425 |
BUN (mmol/L) | 5.27(3.80,7.55) | 4.91(4.02,6.30) | 0.612 |
Cr(umol/L) | 76.0(64.5,93.5) | 73.0(62.5,89.0) | 0.535 |
Hospital stays(days) | 6(5,7) | 5(4,6) | 0.006 |
HBP (ng/mL) | 68.28(41.62,146.92) | 16.18(11.46,27.81) | < 0.001 |
PCT (ug/L) | 0.08(0.05,0.63) | 0.05(0.05,0.05) | < 0.001 |
WBC(×\({10}^{9}\)/L) | 9.85(7.60,12.49) | 6.64(5.51,8.00) | < 0.001 |
Neutrophil(×\({10}^{9}\)/L) | 7.01(5.25,10.50) | 3.70(3.00,5.56) | < 0.001 |
Lymphocyte(×\({10}^{9}\)/L) | 1.06(0.74,1.56) | 1.80(1.29,2.34) | < 0.001 |
NLR | 6.97(3.72,12.58) | 2.35(1.43,3.52) | < 0.001 |
Neutrophil (%) | 81.1(68.3,87.5) | 62.3(51.6,69.0) | < 0.001 |
Lymphocyte (%) | 12.1(6.9,18.9) | 26.7(19.5,35.9) | < 0.001 |
Albumin (g/L) | 33.9 ± 5.57 | 37.6 ± 3.96 | < 0.001 |
HBP/Alb | 2.03(1.24,4.36) | 0.43(0.29,0.77) | < 0.001 |
DDI (mg/L) | 1.00(0.54,2.32) | 0.58(0.31,1.07) | < 0.001 |